Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02787538 · ClinicalTrials.gov registry record · NA
Supporting Patient Care With Electronic Resources in the United States
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02787538: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02787538 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02787538, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This proof-of-concept randomized trial evaluates the effectiveness of using an online decision aid (US-ANSWER-2) in the decision-making to start or switch biologic therapy in US patients with rheumatoid arthritis.
Interventions
- BEHAVIORAL US-ANSWER-2 decision aid
- BEHAVIORAL Control group (Online medication guide)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02787538
The ClinicalTrials.gov registry entry for NCT02787538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which US-ANSWER-2 decision aid is the first listed.
NCT02787538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02787538 about?
NCT02787538 is a clinical study titled "Supporting Patient Care With Electronic Resources in the United States". This proof-of-concept randomized trial evaluates the effectiveness of using an online decision aid (US-ANSWER-2) in the decision-making to start or switch biologic therapy in US patients with rheumatoid arthritis.
What is the current status of trial NCT02787538?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02787538?
The interventions under investigation include: US-ANSWER-2 decision aid (BEHAVIORAL), Control group (Online medication guide) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02787538?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.